RELAIRO Trademark

Trademark Overview

On Tuesday, May 27, 2008, a trademark application was filed for RELAIRO with the United States Patent and Trademark Office. The USPTO has given the RELAIRO trademark a serial number of 77483881. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 16, 2012. This trademark is owned by Glaxo Group Limited. The RELAIRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
relairo

General Information

Serial Number77483881
Word MarkRELAIRO
Filing DateTuesday, May 27, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 16, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
Translation of Words in MarkThe English translation of the word "RELAIRO" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 30, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, July 16, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 16, 2012ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 10, 2012ASSIGNED TO EXAMINER
Friday, December 9, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 8, 2011EXTENSION 5 GRANTED
Tuesday, December 6, 2011EXTENSION 5 FILED
Tuesday, December 6, 2011TEAS EXTENSION RECEIVED
Wednesday, June 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 14, 2011EXTENSION 4 GRANTED
Monday, June 13, 2011EXTENSION 4 FILED
Monday, June 13, 2011TEAS EXTENSION RECEIVED
Friday, October 29, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 28, 2010EXTENSION 3 GRANTED
Tuesday, October 26, 2010EXTENSION 3 FILED
Tuesday, October 26, 2010TEAS EXTENSION RECEIVED
Friday, June 25, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 24, 2010EXTENSION 2 GRANTED
Wednesday, May 26, 2010EXTENSION 2 FILED
Thursday, June 17, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 26, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 3, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 3, 2009EXTENSION 1 GRANTED
Thursday, December 3, 2009EXTENSION 1 FILED
Thursday, December 3, 2009TEAS EXTENSION RECEIVED
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 16, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 24, 2009PUBLISHED FOR OPPOSITION
Wednesday, March 4, 2009NOTICE OF PUBLICATION
Thursday, February 19, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 18, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 9, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 9, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 6, 2009ASSIGNED TO LIE
Thursday, February 5, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 27, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 27, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 9, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 9, 2008NON-FINAL ACTION E-MAILED
Tuesday, September 9, 2008NON-FINAL ACTION WRITTEN
Tuesday, September 9, 2008ASSIGNED TO EXAMINER
Friday, May 30, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

relairo pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic